Potassium-enriched salt could save nearly 3 million lives annually worldwide
Replacing regular sodium chloride with potassium-enriched salt across 193 countries could prevent almost 3 million cardiovascular and kidney-related deaths each year, according to a study published in Nature Health. The research highlights that this simple dietary shift addresses both excess sodium intake and insufficient potassium, major contributors to high blood pressure and related diseases. The World Health Organization has already endorsed the switch as a cost-effective public health strategy.
A landmark study published in Nature Health in 2026 reveals that replacing regular sodium chloride with potassium-enriched salt across all 193 World Health Organization member countries could prevent nearly 3 million cardiovascular and kidney-related deaths annually. The research, led by scientists at The George Institute for Global Health, models a global shift in salt use and finds that even partial adoption—such as targeting high-risk populations—yields substantial health gains, including 10 million fewer new cases of cardiovascular disease each year. The study underscores the dual problem of excessive sodium intake and insufficient potassium consumption, both major contributors to hypertension, which affects one in three adults aged 30–79 globally. The World Health Organization formally endorsed potassium-enriched salt in 2025 as a cost-effective public health intervention, building on prior recommendations about reducing dietary sodium. Key figures like Bruce Neal and Vivek Jha emphasize that the switch is feasible—potassium-enriched salt mimics regular salt in taste and function—and that benefits outweigh risks even for patients with advanced kidney disease, provided clinical oversight and labeling are implemented. However, the transition faces challenges: in high-income regions like Europe and North America, where over 70% of sodium comes from processed foods, industry cooperation is essential. Scaling up potassium chloride production remains a logistical hurdle, and t
The potential widespread adoption of potassium-enriched salt could significantly reduce the global burden of cardiovascular disease, which caused 19.2 million deaths in 2023. If implemented at scale, this intervention may offer a low-cost, scalable alternative to pharmaceutical treatments for hypertension, particularly in low- and middle-income countries where access to medication is limited. The food industry, especially in North America and Europe, would need to adapt its supply chains, possibly reshaping processed food manufacturing and labeling practices. This shift could also influence consumer behavior and public health policy, encouraging broader dietary reforms. A comparable precedent is the successful global reduction of iodine deficiency through salt iodization, which transformed national health outcomes with minimal disruption. However, unlike iodized salt, potassium-enriched salt raises concerns about hyperkalemia in vulnerable populations, requiring careful monitoring. The